University of California, Irvine RADIONUCLIDE HAZARDS INFORMATION For 3H, 14C, 22Na, 32P, 33P, 35S 36 Cl, 45Ca, 51Cr, 99mTc, 125I & 131I February 2004 3 H -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Beta, 18 keV (max) 6 keV (ave) z HALF LIFE: 12.3 years z RANGE IN AIR: 4.5 mm z RANGE IN TISSUE: 0.006 mm DOSE RATES z No external exposure hazard--radiation from this radionuclide will not penetrate the dead layer of skin INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): z SPECIAL COMMENTS 80 mCi--inhalation 80 mCi--oral ingestion 3 3 Most 3H compounds are distributed in body water with ~10 day Effective T1/2 3 H-water is volatile and may release tritiated water vapor H-borohydrides are reactive and may generate tritium gas H-nucleotides/nucleosides may become incorporated into the cellular DNA, resulting in a higher dose to the DNA than to all other organs and tissues INDIVIDUAL MONITORING Urine bioassays may be needed for the use of very large quantities of 3H, such as labeling procedures with 3H-water or 3H-borohydrides. Individual monitoring procedures for 3H will be specified when necessary in the Precautions Section of the Radiation Use Authorization. 3 H DECAY TABLE: Half-life = 12.3 years # of Days Decay Correction # of Days Decay Correction 0 1.00 90 0.99 180 0.97 270 0.96 360 0.95 2 14 C -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Beta, 156 keV (max) 49 keV (ave) z HALF LIFE: 5,730 years z RANGE IN AIR: 22 cm z RANGE IN TISSUE: 0.28 mm EXTERNAL EXPOSURES z No external exposure hazard--radiation from this radionuclide will barely penetrate the dead layer of skin INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): z SPECIAL COMMENTS 2 mCi--inhalation 2 mCi--oral ingestion Most 14C compounds are rapidly metabolized to 14CO2 and are then exhaled with the very short Effective T1/2 of a few days 14 C-nucleotides/nucleosides may become incorporated into the cellular DNA, resulting in a higher dose to the DNA than to all other organs and tissues 3 22 Na -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Gamma, 1.27 Mev, 511 keV Positron, 545 kev, 1.82 MeV (max) 215 kev, 834 kev (ave) z HALF LIFE: 2.6 years z HALF VALUE LAYERS In air: 90 m In tissue: 10 cm In lead: 9 mm EXTERNAL EXPOSURES z z GAMMA DOSE RATES FROM 1 mCi POINT SOURCE @ 5 centimeters: 540 mrem/h @ 1 meter: 1.4 mrem/h SPECIAL COMMENTS Annihilation of positrons produces 511 keV gammas 2 inches or more of lead is needed to shield high energy gammas INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): 600 uCi--inhalation 400 uCi--oral ingestion 4 22 Na (CONTINUED) INDIVIDUAL MONITORING z EXTERNAL EXPOSURE For administrative purposes, a TLD RING BADGE and a TLD BODY BADGE will be worn when handling the following quantities, or more, of 22Na at any one time: FOR WELL SHIELDED OPERATIONS AND STORAGE, 22 * Adults, except Declared Pregnant Women 1 mCi * Declared Pregnant Women and Minors under Age 18 0.1 mCi FOR UNSHIELDED OPERATIONS, STORAGE OR BOTH, * Adults, except Declared Pregnant Women 0.1 mCi * Declared Pregnant Women and Minors under Age 18 0.01 mCi Na DECAY TABLE: Half-life = 2.6 days # of Days Decay Correction # of Days Decay Correction 0 1.00 90 0.94 180 0.88 270 0.82 360 0.77 450 0.72 540 0.67 630 0.63 720 0.59 810 0.55 900 0.52 5 32 P -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Beta, 1.71 MeV (max) 694 keV (ave) z HALF LIFE: 14.3 days z RANGE IN AIR: 610 cm z RANGE IN TISSUE: 0.8 cm EXTERNAL EXPOSURES z z BETA DOSE RATES FROM 1 mCi POINT SOURCE @ 1 centimeter: 1.2 krem/h @ 1 meter: 33 mrem/h SPECIAL COMMENTS Hazard to the lens of the eye and skin without general shielding Hazard to the extremities (fingers) without vial shielding Recommend 0.5 inch of Lucite for shielding to eliminate betas Can have significant x-ray production in heavy shields (such as lead or steel) INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): z SPECIAL COMMENTS 900 uCi--inhalation 600 uCi--oral ingestion 30% of soluble 32P ingested will be deposited in bone 32 32 P-nucleotides/nucleosides are not considered to have a greater hazard than other P compounds 6 32 P (CONTINUED) INDIVIDUAL MONITORING For administrative purposes, a TLD RING BADGE will be worn when handling the following quantities, or more, of 32P at any one time: z z 32 FOR WELL SHIELDED OPERATIONS AND STORAGE, Adults, including Declared Pregnant Women 10 mCi Minors under Age 18 1 mCi FOR UNSHIELDED OPERATIONS, STORAGE OR BOTH, Adults, including Declared Pregnant Women 1 mCi Minors under Age 18 0.1 mCi P DECAY TABLE: Half-life = 14.3 days Days 0 1 2 3 4 5 6 7 8 9 0 1.00 0.95 0.91 0.86 0.82 0.78 0.75 0.71 0.68 0.65 10 0.62 0.59 0.56 0.53 0.51 0.48 0.46 0.44 0.42 0.40 20 0.38 0.36 0.34 0.33 0.31 0.30 0.28 0.27 0.26 0.25 30 0.23 0.22 0.21 0.20 0.19 0.18 0.17 0.17 0.16 0.15 40 0.14 0.14 0.13 0.12 0.12 0.11 0.11 0.10 0.10 0.09 50 0.09 0.08 0.08 0.08 0.07 0.07 0.07 0.06 0.06 0.06 60 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.04 0.04 70 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02 80 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 90 0.01 7 33 P -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Beta, 249 keV (max) 80 kev (ave) z HALF LIFE: 25.4 days z RANGE IN AIR: 45 cm z RANGE IN TISSUE: 0.6 mm EXTERNAL EXPOSURES z No external exposure hazard--radiation from this radionuclide will barely penetrate the dead layer of skin INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): z SPECIAL COMMENTS 33 8 mCi--inhalation 6 mCi--oral ingestion 30% of soluble 33P ingested will be deposited in bone 33 33 P-nucleotides/nucleosides are not considered to have a greater hazard than other P compounds P DECAY TABLE: Half-life = 25.4 days # of Days 0 2 4 6 8 0 1.00 0.95 0.90 0.85 0.80 10 0.76 0.72 0.68 0.65 0.61 20 0.58 0.55 0.52 0.49 0.47 30 0.44 0.42 0.40 0.37 0.36 40 0.34 0.32 0.30 0.29 0.27 50 0.26 0.24 0.23 0.22 0.21 60 0.20 0.18 0.17 0.17 0.16 70 0.15 0.14 0.13 0.13 0.12 80 0.11 0.11 0.10 0.10 0.09 90 0.09 8 35 S -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Beta, 167 keV (max) 48 kev (ave) z HALF LIFE: 87.4 days z RANGE IN AIR: 24.5 cm z RANGE IN TISSUE: 0.3 mm EXTERNAL EXPOSURES z No external exposure hazard--radiation from this radionuclide will barely penetrate the dead layer of skin INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): 8 mCi--oral ingestion z ALI (based on 50 rems CDE): 20 mCi--inhalation 10 mCi--oral ingestion z SPECIAL COMMENTS 35 The ALI (based on 50 rems CDE to the organ or tissue receiving the highest internal dose) applies to the lower large intestine wall 35 35 S-nucleotides/nucleosides are not considered to have a greater hazard than other S compounds S DECAY TABLE: Half-life = 87.4 days # of Weeks Decay Correction # of Weeks Decay Correction 0 1.00 1 0.95 2 0.89 3 0.85 4 0.80 5 0.76 6 0.72 7 0.68 8 0.64 9 0.61 10 0.57 11 0.54 12 0.51 13 0.49 9 36 Cl -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Beta, 710 keV (max) 200 keV (ave) z HALF LIFE: 3 x 105 years z RANGE IN AIR: 200 cm z RANGE IN TISSUE: 0.3 cm EXTERNAL EXPOSURES z z BETA DOSE RATES FROM 1 mCi POINT SOURCE @ 1 centimeter: 600 rem/h @ 1 meter: 13 mrem/h SPECIAL COMMENTS Hazard to the lens of the eye and skin without general shielding Hazard to the extremities (fingers) without vial shielding Recommend 0.5 inch of Lucite for shielding to eliminate betas Can have significant x-ray production in heavy shields (such as lead or steel) INTERNAL EXPOSURES z FOR CHLORIDES OF H, Li, Na, K, Rb, Cs, Fr ALI (based on 5 rems CEDE): z 2 mCi--inhalation 2 mCi--oral ingestion FOR OTHER CHLORIDES ALI (based on 5 rems CEDE): 200 uCi--inhalation 10 36 Cl (CONTINUED) INDIVIDUAL MONITORING For administrative purposes, a TLD RING BADGE will be worn when handling the following quantities, or more, of 36Cl at any one time: z z FOR WELL SHIELDED OPERATIONS AND STORAGE, Adults, including Declared Pregnant Women 10 mCi Minors under Age 18 1 mCi FOR UNSHIELDED OPERATIONS, STORAGE OR BOTH, Adults, including Declared Pregnant Women 1 mCi Minors under Age 18 0.1 mCi 11 45 Ca -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Beta, 257 keV (max) 86 (ave) z HALF LIFE: 163 days z RANGE IN AIR: 48 cm z RANGE IN TISSUE: 0.6 mm EXTERNAL EXPOSURES z No external exposure hazard--radiation from this radionuclide will barely penetrate the dead layer of skin INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): z Most of 45Ca intake is deposited in bone with a long Effective T1/2 approaching the Physical T1/2 45 800 uCi--inhalation 2 mCi--oral ingestion Ca DECAY TABLE: Half-life = 163 days # of Weeks Decay Correction # of Weeks Decay Correction 0 1.00 1 0.97 2 0.94 3 0.91 4 0.89 5 0.86 6 0.84 7 0.81 8 0.79 9 0.77 10 0.74 11 0.72 12 0.70 13 0.68 12 51 Cr -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Gamma, 320 keV z HALF LIFE: 27.7 days z HALF VALUE LAYERS In air: 54 m In tissue: 6 cm In lead: 2 mm EXTERNAL EXPOSURES z z DOSE RATES FROM 1 mCi POINT SOURCE @ 5 centimeters: 6.4 mrem/h @ 1 meter: 0.02 mrem/h SPECIAL COMMENTS 1/2 inch of lead is adequate to shield medium energy gammas INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): 50 mCi--inhalation 40 mCi--oral ingestion INDIVIDUAL MONITORING z EXTERNAL EXPOSURE For administrative purposes, a RING BADGE will be worn when handling the following quantities, or more, of 51Cr at any one time: FOR WELL SHIELDED OPERATIONS AND STORAGE, * Adults, except Declared Pregnant Women 10 mCi * Declared Pregnant Women and Minors under Age 18 1 mCi 13 51 51 Cr (CONTINUED) FOR UNSHIELDED OPERATIONS, STORAGE OR BOTH, * Adults, except Declared Pregnant Women 1 mCi * Declared Pregnant Women and Minors under Age 18 0.1 mCi Cr DECAY TABLE: Half-life = 27.7 days Days 0 2 4 6 8 0 1.00 0.95 0.90 0.86 0.82 10 0.78 0.74 0.70 0.67 0.64 20 0.61 0.58 0.55 0.52 0.50 30 0.47 0.45 0.43 0.41 0.39 40 0.37 0.35 0.33 0.32 0.30 50 0.29 0.27 0.26 0.25 0.23 60 0.22 0.21 0.20 0.19 0.18 70 0.17 0.17 0.16 0.15 0.14 80 0.14 0.13 0.12 0.12 0.11 90 0.11 14 99m Tc -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Gamma, 140 keV z HALF LIFE: 6 hours z HALF VALUE LAYERS In air: 37.6 m In tissue: 4.5 cm In lead: 0.25 mm EXTERNAL EXPOSURES z z DOSE RATES FROM 1 mCi POINT SOURCE @ 5 centimeters: 50 mrem/h @ 1 meter: 0.12 mrem/h SPECIAL COMMENTS 1/2 inch of lead is adequate to shield medium energy gammas INTERNAL EXPOSURES z FOR OXIDES, HYDROXIDES, HALIDES AND NITRATES z ALI (based on 5 rems CEDE): 200 mCi--inhalation FOR ALL OTHER COMPOUNDS ALI (based on 5 rems CEDE): 200 mCi--inhalation 80 mCi--oral ingestion 15 99m Tc (CONTINUED) INDIVIDUAL MONITORING z EXTERNAL EXPOSURE For administrative purposes, a TLD RING BADGE will be worn when handling the following quantities, or more, of 99mTc at any one time: FOR WELL SHIELDED OPERATIONS AND STORAGE, * Adults, except Declared Pregnant Women 10 mCi * Declared Pregnant Women and Minors under Age 18 1 mCi FOR UNSHIELDED OPERATIONS, STORAGE OR BOTH, * Adults, except Declared Pregnant Women 1 mCi * Declared Pregnant Women and Minors under Age 18 0.1 mCi 99m Tc DECAY TABLE: Half-life = 6.0 hours # of Hours 0 2 4 6 8 0 1.00 0.79 0.63 0.50 0.40 10 0.32 0.25 0.20 0.16 0.13 20 0.10 0.08 0.06 0.05 0.04 30 0.03 0.02 0.02 0.02 0.01 40 0.01 16 125 I -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Gamma & EC X-Ray, 35 keV z HALF LIFE: 60.2 days z HALF VALUE LAYERS In air: 24 m In tissue: 2.3 cm In lead: 0.02 mm EXTERNAL EXPOSURES z z GAMMA DOSE RATES FROM 1 mCi POINT SOURCE @ 5 centimeters: 30 mrem/h @ 1 meter: 0.07 mrem/h SPECIAL COMMENTS Thin lead foil is adequate to shield low energy gammas and electron capture xrays INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): 200 uCi--inhalation 100 uCi--oral ingestion z ALI (based on 50 rems CDE): 60 uCi--inhalation 40 uCi--oral ingestion z SPECIAL COMMENTS The ALI (based on 50 rems CDE to the organ or tissue receiving the highest internal dose) applies to the thyroid gland 17 125 125 I (CONTINUED) I-sodium iodide is very volatile * The process of opening a vial of this labeled compound outside of a fume hood can result in significant airborne radioactive contamination * Reducing the pH of this labeled compound to less than 7 may result in a much increased release of airborne radioactivity 125 I-sodium iodide or other volatile forms must be handled in an EH&S approved fume hood with * An inner pair of shoulder-length impervious gloves, and * An outer pair of standard-length impervious gloves 125 I-nucleotides/nucleosides may become incorporated into the cellular DNA, resulting in a higher dose to the DNA than to all other organs and tissues 125 I in RIA kits is not volatile and such kits only contain small quantities of radioiodine INDIVIDUAL MONITORING z EXTERNAL EXPOSURE For administrative purposes, a RING BADGE will be worn when handling the following quantities, or more, of 125I at any one time: FOR WELL SHIELDED OPERATIONS AND STORAGE, * Adults, except Declared Pregnant Women 10 mCi * Declared Pregnant Women and Minors under Age 18 1 mCi FOR UNSHIELDED OPERATIONS, STORAGE OR BOTH, * Adults, except Declared Pregnant Women 1 mCi * Declared Pregnant Women and Minors under Age 18 0.1 mCi 18 125 z I (CONTINUED) INTERNAL EXPOSURE For administrative purposes, confirmatory THYROID COUNTS will be performed at the indicated frequencies (given in parentheses below) for individuals performing iodinations, labeling or experimental procedures with the following quantities, or more, of 125I at any one time in an EH&S approved fume hood: 125 FOR SODIUM IODIDE OR OTHER VOLATILE FORMS * Adults, Except Declared Pregnant Women (Quarterly) 10 mCi * Declared Pregnant Women and Minors under Age 18 (Monthly) 1 mCi FOR ALL NONVOLATILE FORMS * Adults, Except Declared Pregnant Women (Every 2 Weeks) 100 mCi * Declared Pregnant Women and Minors under Age 18 (Weekly) 10 mCi I DECAY TABLE: Half-life = 60.2 days Days 0 2 4 6 8 0 1.00 0.98 0.95 0.93 0.91 10 0.89 0.87 0.85 0.83 0.81 20 0.79 0.78 0.76 0.74 0.72 30 0.71 0.69 0.68 0.66 0.65 40 0.63 0.61 0.60 0.59 0.58 50 0.56 0.55 0.54 0.52 0.51 60 0.50 0.49 0.48 0.47 0.46 70 0.45 0.44 0.43 0.42 0.41 80 0.40 0.44 0.38 0.37 0.36 90 0.35 19 131 I -- HAZARDS INFORMATION PHYSICAL DATA z RADIATION: Gamma, 364 keV, 637 keV, 284 keV Beta, 606 kev, 334 keV, 247 keV (max) 191 kev, 97 kev, 69 kev (ave) z HALF LIFE: 8.05 days z HALF VALUE LAYERS In air: 55 m In tissue: 6.2 cm In lead: 2 mm EXTERNAL EXPOSURES z z GAMMA DOSE RATES FROM 1 mCi POINT SOURCE @ 5 centimeters: 112 mrem/h @ 1 meter: 0.28 mrem/h SPECIAL COMMENTS 2 inches of lead is needed to shield high energy gammas INTERNAL EXPOSURES z ALI (based on 5 rems CEDE): 200 uCi--inhalation 90 uCi--oral ingestion z ALI (based on 50 rems CDE): 50 uCi--inhalation 30 uCi--oral ingestion z SPECIAL COMMENTS The ALI (based on 50 rems CDE to the organ or tissue receiving the highest internal dose) applies to the thyroid gland 131 131 I-nucleotides/nucleosides are not considered to have a greater hazard than other I compounds 20 131 131 I (CONTINUED) I-sodium iodide is very volatile * The process of opening a vial of this labeled compound outside of a fume hood can result in significant airborne radioactive contamination * Reducing the pH of this labeled compound to less than 7 may result in a much increased release of airborne radioactivity 131 I-sodium iodide or other volatile forms must be handled in an EH&S approved fume hood with * An inner pair of shoulder-length impervious gloves, and * An outer pair of standard-length impervious gloves INDIVIDUAL MONITORING z EXTERNAL EXPOSURE For administrative purposes, a TLD RING BADGE and a TLD BODY BADGE will be worn for handling the following quantities, or more, of 131I at any one time: FOR WELL SHIELDED OPERATIONS AND STORAGE, * Adults, except Declared Pregnant Women 1 mCi * Declared pregnant Women and Minors under Age 18 0.1 mCi FOR UNSHIELDED OPERATIONS, STORAGE OR BOTH, * Adults, except Declared Pregnant Women 0.1 mCi * Declared Pregnant Women and Minors under Age 18 0.01 mCi 21 131 z I (CONTINUED) INTERNAL EXPOSURE For administrative purposes, confirmatory THYROID COUNTS will be performed at the indicated frequencies (given in the parentheses below) for individuals performing iodinations, labeling or experimental procedures with the following quantities, or more, of 131I at any one time in an EH&S approved fume hood: FOR SODIUM IODIDE OR OTHER VOLATILE FORMS 131 * Adults, Except Declared Pregnant Women (Monthly) 10 mCi * Declared Pregnant Women and Minors under Age 18 (Every 2 Weeks) 1 mCi FOR ALL NONVOLATILE FORMS * Adults, Except Declared Pregnant Women (Every 2 Weeks) 100 mCi * Declared Pregnant Women and Minors under Age 18 (Weekly) 10 mCi I DECAY TABLE: Half-life = 8.05 days Days 0 1 2 3 4 5 6 7 8 9 0 1.00 0.92 0.84 0.77 0.71 0.65 0.60 0.55 0.50 0.46 10 0.42 0.39 0.36 0.33 0.30 0.27 0.25 0.23 0.21 0.19 20 0.18 0.16 0.15 0.14 0.13 0.12 0.11 0.10 0.09 0.08 30 0.08 0.07 0.06 0.06 0.05 0.05 0.05 0.04 0.04 0.03 40 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.01 50 0.01 22
© Copyright 2026 Paperzz